ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -87.4% | 22 | -75.8% | 0.00% | – |
| Q2 2023 | $1,947 | +337.5% | 91 | +727.3% | 0.00% | – |
| Q1 2023 | $445 | -75.5% | 11 | -71.8% | 0.00% | – |
| Q4 2022 | $1,814 | +81.4% | 39 | +200.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 13 | -84.9% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +500.0% | 86 | +561.5% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 13 | -45.8% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 24 | -54.7% | 0.00% | -100.0% |
| Q2 2020 | $3,000 | +50.0% | 53 | +60.6% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |